AGA Medical commences trial for stroke-prevention 'plug'

June 16, 2010 by MedCity News

AGA Medical Inc. enrolls first subjest in clinical trial of cardiac device for preventing strokes in patients with abnormal heartbeats.

MedCity News logo

By Brandon Glenn

AGA Medical Inc. (NSDQ:AGAM) enrolled the first patient in a clinical trial of a cardiac device aimed at preventing strokes in patients with abnormal heartbeats.

CEO John Barr called the first enrollment in the company’s Amplatzer Cardiac Plug trial “a significant milestone” for the company, according to a statement from AGA.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp